Barrie Colts Sign Former QMJHL Import Gleb Olkhovik
Nov 10, 2026 8:45 PM

The Russian played in five games with the Shawinigan Cataractes before being waived last week.

The Barrie Colts have filled their third import spot on Tuesday, announcing the signing of Russian forward Gleb Olkhovik, who they claimed off waivers Monday.

Olkhovik, 17, was released by the QMJHL's Shawinigan Cataractes last week after playing in five games with the team, recording one assist.

Bizarrely, the reason the Quebecois team let him go is because they signed former Colts import Elias Matousek, who Barrie let go in October. Essentially, this ends up working out as some sort of inter-league import trade, which is not a particularly common occurrence in the CHL.

Barrie's brass clearly sees some potential in the 6-foot-3 winger, who starred with CSKA Moscow's youth teams before being made a second-round pick by Shawinigan in this summer's import draft.

Related stories

“Gleb is a player we were interested in at import draft," Colts GM Marty Williamson said in a press release. "He’s a big strong left shot forward that just needs to find his footing with the North American game. We are excited to develop him with the Barrie Colts."

This signing re-fills the third import spot on Barrie's roster, which was opened with Matousek's departure. Goaltender Matvei Nikonovich and forward Maxim Shriochenkov currently occupy the other two European spots on the roster.

The Colts sit dead last in the OHL with just nine points from their opening 19 games of the 2026-27 season, which was always expected to be a rebuilding year after last season's trip to the OHL championship series.

In a season focused on development, they'll see what upside they can find in this big Russian winger.

Never want to miss out on any OHL news? Make sure to bookmark THN's OHL site.

Also follow @AustinReporting and @roryyarthur on X/Twitter for more updates.

1
Comments
anonymous profile image
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy